LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 59.85 | 27.76 | 1563 | 6062 | 0.2578 | 0.6799 | MN20160318_Q01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 61.56 | 27.76 | 1190 | 6217 | 0.1914 | 0.6183 | MN20160318_Q01 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 61.56 | 27.76 | 1199 | 6217 | 0.1929 | 0.6199 | MN20160318_Q01 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 61.56 | 27.76 | 203 | 6217 | 0.0327 | 0.2903 | MN20160318_Q01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 61.56 | 27.76 | 1691 | 6217 | 0.2720 | 0.6928 | MN20160318_Q01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 63.26 | 27.76 | 1215 | 6465 | 0.1879 | 0.6170 | MN20160318_Q01 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 63.26 | 27.76 | 1225 | 6465 | 0.1895 | 0.6187 | MN20160318_Q01 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 63.26 | 27.76 | 215 | 6465 | 0.0333 | 0.2974 | MN20160318_Q01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 63.26 | 27.76 | 1623 | 6465 | 0.2510 | 0.6776 | MN20160318_Q01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 64.97 | 27.76 | 1199 | 6656 | 0.1801 | 0.6101 | MN20160318_Q01 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 64.97 | 27.76 | 1209 | 6656 | 0.1816 | 0.6118 | MN20160318_Q01 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 64.97 | 27.76 | 180 | 6656 | 0.0270 | 0.2668 | MN20160318_Q01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 64.97 | 27.76 | 1623 | 6656 | 0.2438 | 0.6730 | MN20160318_Q01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 66.67 | 27.76 | 1297 | 6695 | 0.1937 | 0.6254 | MN20160318_Q01 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 66.67 | 27.76 | 1309 | 6695 | 0.1955 | 0.6273 | MN20160318_Q01 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 66.67 | 27.76 | 191 | 6695 | 0.0285 | 0.2760 | MN20160318_Q01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 66.67 | 27.76 | 1675 | 6695 | 0.2502 | 0.6788 | MN20160318_Q01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 68.37 | 27.76 | 1282 | 6879 | 0.1864 | 0.6192 | MN20160318_Q01 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 68.37 | 27.76 | 1290 | 6879 | 0.1875 | 0.6204 | MN20160318_Q01 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 68.37 | 27.76 | 195 | 6879 | 0.0283 | 0.2778 | MN20160318_Q01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 68.37 | 27.76 | 1780 | 6879 | 0.2588 | 0.6874 | MN20160318_Q01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 70.08 | 27.76 | 1306 | 6849 | 0.1907 | 0.6235 | MN20160318_Q01 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 70.08 | 27.76 | 1319 | 6849 | 0.1926 | 0.6256 | MN20160318_Q01 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 70.08 | 27.76 | 189 | 6849 | 0.0276 | 0.2730 | MN20160318_Q01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 70.08 | 27.76 | 1682 | 6849 | 0.2456 | 0.6761 | MN20160318_Q01 | N22 |